NTRK2 and Cognitive impairment: Taken together, these findings support the conclusion that inhibition of AHN at least partially lead to cognitive impairment caused by sevoflurane, which is probably attributed to the downregulation of BDNF/TrkB and NT-3/TrkC pathways.